Searched for
RAVI LIMAYE
BSE CEO Ashish Kumar Chauhan to head NSE for 5 yearsThough Limaye was eligible for a reappointment, he backed out of the race. Until Chauhan takes charge at NSE, the bourse, as per Sebi's dir...- Don't leak info, NSE tells top executivesThe country's largest stock exchange is also willing to put in place a new mechanism, over and above what currently exists, to address grie...
- NSE begins hunt for MD, CEO; invites applicationsListing out eligibility criteria, NSE's notice stated that the candidate must have a track record of strengthening corporate governance, en...
- Wockhardt snags Covid-19 vaccine manufacturing deal from the UK govtThis deal by Wockhardt entails only manufacturing the vaccine only for the United Kingdom. The government has reserved one fill and finish ...
- Sebi fines NSE Rs 1,100 crore, bans two ex-MDs in brokers’ scamFor its role in the scam, Sebi also banned NSE from the stock market for six months.
- SC appoints PS Narasimha as mediator to resolve disputes of cricket administration in BCCIA bench of Justices S A Bobde and A M Spare was informed by Narasimha that former apex court judge Justice (retd) D K Jain has assumed char...
- SC appoints Lt Gen Ravi Thodge as 3rd member of CoA for BCCIA bench of Justices S A Bobde and A M Sapre appointed Lt Gen Thodge as a member of CoA after senior advocate P S Narasimha, assisting the c...
- Former and current NSE executives opt for consent mode to settle co-location caseConsent orders are similar to an out-of-court settlement in securities law parlance.
- NSE chief Vikram Limaye's parenting tip: Money important, but value system, skills essentialLimaye is often the go-to man for seemingly daunting top jobs.
- Appointment of the support staff has been a forgettable sagaThe whole process has been reduced to a tussle between Shastri and the CAC in the media. Indian Cricket, interestingly, doesn't even featur...
- NSE's Chitra Ramkrishna earned Rs 23 crore in 8 months of FY'17Vikram Limaye, who joined NSE from today, would get a pay package of Rs 8 crore.
- Sebi to approve Vikram Limaye’s appointment as MD and CEO of NSEVikram Limaye will take charge at NSE once relieved from CoA duties at BCCI.
- Probe gathers pace: Sebi show-cause to NSE, 14 officials in algo trade caseNSE officials in question are taking legal advice to prepare their response for sebi.
- Buy Biocon Ltd. target Rs 1234.0 : Rakesh BansalBuy Biocon Ltd. at a price target of Rs 1234.0 and a stoploss at Rs 1107.0 from entry point
- NSE shareholders approve Limaye's appointment as MD and CEOLimaye, who is currently serving as chief of IDFC, was selected by the board of National Stock Exchange (NSE) in February.
- Varanasi, Kannan lead race for NSE top postOver the last couple of weeks, the panel has met Leo Puri, MD, UTI Mutual Fund, Vikram Limaye, MD of IDFC, Sanjeev Kaushik, DMD at IFCI and...
- Biocon shares gain over 5%, hit 52-week high intra-dayShares of biotechnology major Biocon today surged over 5 per cent after the company launched advanced novel therapy for the treatment of He...
- Biocon introduces advanced therapy to treat Hepatitis CBiotechnology major Biocon launches advanced novel therapy for the treatment of Hepatitis C at a fraction of the global cost.
- Biocon posts 15% rise in revenue, names new CEOBiocon, the country's largest biotech company, reported a 15% rise in fourth-quarter revenue to 746 crore, helped by a 17% rise in sales at...
- GSK enters into agreement with Japan-based Astellas PharmaDrug firm GlaxoSmithkline Pharmaceuticals on Monday said it has enter into a collaboration with the Japan-based Astellas Pharma Inc for sel...
Load More
